Literature DB >> 9717414

Treatment of clinically severe obesity, a public health problem: introduction.

R Alvarez-Cordero.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9717414     DOI： 10.1007/pl00012295

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  5 in total

1.  Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery.

Authors:  Mohamed Hassan Saleh; Marcelo Chiara Bertolami; Jorge Eduardo Assef; Mohamed Ibrahim Taha; Wilson de Freitas; Ana Claudia Gomes Petisco; Rodrigo Bellio Mattos Barretto; David Costa Le Bihan; Jose Eduardo Martins Barbosa; Carlos Alberto de Jesus; Amanda Guerra Moraes Rego Sousa
Journal:  Obes Surg       Date:  2012-11       Impact factor: 4.129

2.  Clinical and Metabolic Effects of Biliopancreatic Diversion Persist After Reduction of the Gastric Pouch and Elongation of the Common Alimentary Tract. Preliminary Report in a Series of Patients with a 10-Year Follow-Up.

Authors:  Valerio Ceriani; Francesco Cetta; Tiziana Lodi; Ferdinando Pinna; Antonio E Pontiroli
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

3.  Age-Related Effects of Bariatric Surgery on Early Atherosclerosis and Cardiovascular Risk Reduction.

Authors:  Frederik H W Jonker; Vera A A van Houten; Leontine H Wijngaarden; René A Klaassen; André A E A de Smet; André Niezen; Lodewijk J D M Schelfhout; Tobias A Bruning; Erwin van der Harst
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

Review 4.  Intragastric balloon for obesity.

Authors:  M Fernandes; A N Atallah; B G O Soares; S Humberto; S Guimarães; D Matos; L Monteiro; B Richter
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

5.  Laparoscopic Roux-en-Y gastric bypass for recalcitrant gastroesophageal reflux disease in morbidly obese patients.

Authors:  Yaron Perry; Anita P Courcoulas; Hiran C Fernando; Percival O Buenaventura; James S McCaughan; James D Luketich
Journal:  JSLS       Date:  2004 Jan-Mar       Impact factor: 2.172
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.